Getein Biotech, Inc (SHA:603387)

Getein Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	370.63	313.88	351.6	484.33	646.25	968.9
Trading Asset Securities	1,309	912.63	648.88	451.91	511.14	612.68
Cash & Short-Term Investments	1,680	1,227	1,000	936.24	1,157	1,582
Cash Growth	46.09%	22.59%	6.86%	-19.11%	-26.82%	13.26%
Accounts Receivable	333.58	362.09	359.65	453.18	502.1	445.96
Other Receivables	51.96	71.53	50.29	133.31	37.36	37.45
Receivables	385.54	433.62	409.94	586.49	539.45	483.41
Inventory	189.11	183.83	194.46	229.71	269.39	252.3
Other Current Assets	306.13	458.73	252.18	398.75	433.12	48.13
Total Current Assets	2,561	2,303	1,857	2,151	2,399	2,365
Property, Plant & Equipment	718.72	724.05	707.48	703.86	556.49	452.2
Long-Term Investments	158.71	449.42	889.75	641.21	223.6	142.86
Goodwill	12.02	12.02	0.31	26.14	26.14	26.14
Other Intangible Assets	167.29	172.94	141.55	113.79	103.91	77.21
Long-Term Accounts Receivable	-	1.98	4.9	8.23	9.25	10.93
Long-Term Deferred Tax Assets	61.11	57.83	47.89	43.18	35.48	14.92
Long-Term Deferred Charges	32.63	31.49	55.07	80.12	51.05	43.68
Other Long-Term Assets	58.75	3.52	3.39	3.92	273.63	4.56
Total Assets	3,770	3,756	3,707	3,772	3,679	3,138

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	167.87	126.65	77.4	73.73	102.95	110.97
Accrued Expenses	44.67	98.95	98.39	103.03	120.22	85
Short-Term Debt	339.84	479.89	575.57	641.29	551.94	464.37
Current Portion of Long-Term Debt	0.79	-	-	12.89	25.8	0.2
Current Portion of Leases	-	0.77	4.38	9.79	5.63	2.1
Current Income Taxes Payable	21.79	10.55	12.2	9.58	9.04	10.48
Current Unearned Revenue	49.41	39.35	34.87	38.17	75.37	94.29
Other Current Liabilities	56.63	99.01	137.22	90.91	67.12	46.08
Total Current Liabilities	681	855.17	940.01	979.38	958.06	813.48
Long-Term Debt	-	-	-	-	3	27.78
Long-Term Leases	0.89	1.3	1.62	2.71	4.65	2
Long-Term Unearned Revenue	14.42	15.71	18.3	20.88	23.47	5.87
Long-Term Deferred Tax Liabilities	27.92	24.37	26.48	27.41	24.2	13.96
Other Long-Term Liabilities	-	-	-	-	0.91	0.8
Total Liabilities	724.23	896.55	986.42	1,030	1,014	863.9

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	507.15	507.15	507.15	507.15	507.15	363.81
Additional Paid-In Capital	314.73	236.9	236.18	314.01	318.24	511.58
Retained Earnings	2,103	1,995	1,865	1,732	1,655	1,280
Treasury Stock	-	-	-	-	-	-50
Comprehensive Income & Other	14.63	13.84	10.16	5.87	1.69	1.37
Total Common Equity	2,940	2,753	2,619	2,559	2,482	2,106
Minority Interest	106.09	106.65	101.99	181.92	182.13	167.63
Shareholders' Equity	3,046	2,859	2,721	2,741	2,665	2,274
Total Liabilities & Equity	3,770	3,756	3,707	3,772	3,679	3,138

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	341.53	481.96	581.57	666.68	591.02	496.44
Net Cash (Debt)	1,338	744.54	418.9	269.56	566.37	1,085
Net Cash Growth	190.72%	77.74%	55.40%	-52.41%	-47.81%	7.27%
Net Cash Per Share	2.69	1.48	0.82	0.53	1.11	2.12
Filing Date Shares Outstanding	515.15	507.15	507.15	507.15	507.15	507.15
Total Common Shares Outstanding	515.15	507.15	507.15	507.15	507.15	507.15
Working Capital	1,880	1,448	917.03	1,172	1,441	1,552
Book Value Per Share	5.71	5.43	5.16	5.05	4.89	4.15
Tangible Book Value	2,760	2,568	2,477	2,419	2,352	2,003
Tangible Book Value Per Share	5.36	5.06	4.88	4.77	4.64	3.95
Buildings	-	285.91	273.29	247.34	243.57	240.18
Machinery	-	528.69	527.67	529.3	440.02	296.94
Construction In Progress	-	272.63	225.08	205.76	86.37	80.86

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error